Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Silence Therapeutics plc
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
|
|
|
|
| Table 1 – Newly Registered Securities | |||||||
| Security | Security Class | Fee | Amount | Proposed | Maximum | Fee Rate | Amount of |
Fees to be Paid | Equity | Ordinary Shares, nominal value £0.05 per share, to be issued upon the exercise of outstanding options granted under the 2018 Employee LTIP with US Employee Sub-Plan and 2018 Non-Employee LTIP with US Non-Employee Sub-Plan | Other(3) | 10,812,387(4) | $18,272,943.03 | $1.69 | $0.0001102 | $2,013.68
|
Fees to be Paid | Equity | Ordinary Shares, nominal value £0.05 per share, to be issued upon the exercise of options to be granted under the 2023 Equity Incentive Plan with Non-Employee Sub-Plan and CSOP Sub-Plan | Other(3) | 3,000,000(5)(6) | $5,065,000.00 | $1.69 | $0.0001102 | $558.16 |
| Total Offering Amounts | 13,812,387 | – | $1.69 | – | $2,571.84 | ||
| Total Fees Previously Paid |
| – | – | – | – | ||
| Total Fee Offsets |
| – | – | – | – | ||
| Net Fee Due |
| – | – | – | $2,571.84 |
286163047 v7